Login / Signup

How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?

E Sila OzdemirSrivathsan V RanganathanRuth Nussinov
Published in: Expert opinion on drug discovery (2022)
Keyphrases
  • artificial intelligence
  • coronavirus disease
  • sars cov
  • machine learning
  • big data
  • deep learning
  • adverse drug
  • drug induced
  • respiratory syndrome coronavirus
  • emergency department
  • electronic health record